Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.
Dengue viruses (DENV) are enveloped single-stranded positive-sense RNA viruses transmitted by Aedes spp. mosquitoes. There are four genetically distinct serotypes designated DENV-1 through DENV-4, each further subdivided into distinct genotypes. The dengue scientific community has long contended tha...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001486&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841527010459910144 |
|---|---|
| author | William B Messer Boyd Yount Kari E Hacker Eric F Donaldson Jeremy P Huynh Aravinda M de Silva Ralph S Baric |
| author_facet | William B Messer Boyd Yount Kari E Hacker Eric F Donaldson Jeremy P Huynh Aravinda M de Silva Ralph S Baric |
| author_sort | William B Messer |
| collection | DOAJ |
| description | Dengue viruses (DENV) are enveloped single-stranded positive-sense RNA viruses transmitted by Aedes spp. mosquitoes. There are four genetically distinct serotypes designated DENV-1 through DENV-4, each further subdivided into distinct genotypes. The dengue scientific community has long contended that infection with one serotype confers lifelong protection against subsequent infection with the same serotype, irrespective of virus genotype. However this hypothesis is under increased scrutiny and the role of DENV genotypic variation in protection from repeated infection is less certain. As dengue vaccine trials move increasingly into field-testing, there is an urgent need to develop tools to better define the role of genotypic variation in DENV infection and immunity. To better understand genotypic variation in DENV-3 neutralization and protection, we designed and constructed a panel of isogenic, recombinant DENV-3 infectious clones, each expressing an envelope glycoprotein from a different DENV-3 genotype; Philippines 1982 (genotype I), Thailand 1995 (genotype II), Sri Lanka 1989 and Cuba 2002 (genotype III) and Puerto Rico 1977 (genotype IV). We used the panel to explore how natural envelope variation influences DENV-polyclonal serum interactions. When the recombinant viruses were tested in neutralization assays using immune sera from primary DENV infections, neutralization titers varied by as much as ∼19-fold, depending on the expressed envelope glycoprotein. The observed variability in neutralization titers suggests that relatively few residue changes in the E glycoprotein may have significant effects on DENV specific humoral immunity and influence antibody mediated protection or disease enhancement in the setting of both natural infection and vaccination. These genotypic differences are also likely to be important in temporal and spatial microevolution of DENV-3 in the background of heterotypic neutralization. The recombinant and synthetic tools described here are valuable for testing hypotheses on genetic determinants of DENV-3 immunopathogenesis. |
| format | Article |
| id | doaj-art-2c28051283544cb08e496065d0e40d2d |
| institution | Kabale University |
| issn | 1935-2727 1935-2735 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Neglected Tropical Diseases |
| spelling | doaj-art-2c28051283544cb08e496065d0e40d2d2025-01-16T05:32:28ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352012-01-0162e148610.1371/journal.pntd.0001486Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.William B MesserBoyd YountKari E HackerEric F DonaldsonJeremy P HuynhAravinda M de SilvaRalph S BaricDengue viruses (DENV) are enveloped single-stranded positive-sense RNA viruses transmitted by Aedes spp. mosquitoes. There are four genetically distinct serotypes designated DENV-1 through DENV-4, each further subdivided into distinct genotypes. The dengue scientific community has long contended that infection with one serotype confers lifelong protection against subsequent infection with the same serotype, irrespective of virus genotype. However this hypothesis is under increased scrutiny and the role of DENV genotypic variation in protection from repeated infection is less certain. As dengue vaccine trials move increasingly into field-testing, there is an urgent need to develop tools to better define the role of genotypic variation in DENV infection and immunity. To better understand genotypic variation in DENV-3 neutralization and protection, we designed and constructed a panel of isogenic, recombinant DENV-3 infectious clones, each expressing an envelope glycoprotein from a different DENV-3 genotype; Philippines 1982 (genotype I), Thailand 1995 (genotype II), Sri Lanka 1989 and Cuba 2002 (genotype III) and Puerto Rico 1977 (genotype IV). We used the panel to explore how natural envelope variation influences DENV-polyclonal serum interactions. When the recombinant viruses were tested in neutralization assays using immune sera from primary DENV infections, neutralization titers varied by as much as ∼19-fold, depending on the expressed envelope glycoprotein. The observed variability in neutralization titers suggests that relatively few residue changes in the E glycoprotein may have significant effects on DENV specific humoral immunity and influence antibody mediated protection or disease enhancement in the setting of both natural infection and vaccination. These genotypic differences are also likely to be important in temporal and spatial microevolution of DENV-3 in the background of heterotypic neutralization. The recombinant and synthetic tools described here are valuable for testing hypotheses on genetic determinants of DENV-3 immunopathogenesis.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001486&type=printable |
| spellingShingle | William B Messer Boyd Yount Kari E Hacker Eric F Donaldson Jeremy P Huynh Aravinda M de Silva Ralph S Baric Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. PLoS Neglected Tropical Diseases |
| title | Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. |
| title_full | Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. |
| title_fullStr | Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. |
| title_full_unstemmed | Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. |
| title_short | Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. |
| title_sort | development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization |
| url | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001486&type=printable |
| work_keys_str_mv | AT williambmesser developmentandcharacterizationofareversegeneticsystemforstudyingdenguevirusserotype3strainvariationandneutralization AT boydyount developmentandcharacterizationofareversegeneticsystemforstudyingdenguevirusserotype3strainvariationandneutralization AT kariehacker developmentandcharacterizationofareversegeneticsystemforstudyingdenguevirusserotype3strainvariationandneutralization AT ericfdonaldson developmentandcharacterizationofareversegeneticsystemforstudyingdenguevirusserotype3strainvariationandneutralization AT jeremyphuynh developmentandcharacterizationofareversegeneticsystemforstudyingdenguevirusserotype3strainvariationandneutralization AT aravindamdesilva developmentandcharacterizationofareversegeneticsystemforstudyingdenguevirusserotype3strainvariationandneutralization AT ralphsbaric developmentandcharacterizationofareversegeneticsystemforstudyingdenguevirusserotype3strainvariationandneutralization |